The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer

Breast cancer is the most prevalent cancer in women worldwide. About 15-20% of all breast cancers do not express estrogen receptor, progesterone receptor or HER2 receptor and hence are collectively classified as triple negative breast cancer (TNBC). These tumors are often relatively aggressive when...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Xinyan, Saddiq, Muhammad Zahari, Renuse, Santosh, Kelkar, Dhanashree S, Barbhuiya, Mustafa A, Rojas, Pamela L, Stearns, Vered, Gabrielson, Edward, Malla, Pavani, Sukumar, Saraswati, Mahajan, Nupam P, Pandey, Akhilesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356856/
https://www.ncbi.nlm.nih.gov/pubmed/27902967
http://dx.doi.org/10.18632/oncotarget.13579

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356856/
https://www.ncbi.nlm.nih.gov/pubmed/27902967
http://dx.doi.org/10.18632/oncotarget.13579

Ejemplares similares